Clinical trial

SLMAP and EPO Genetic Polymorphism in Diabetic Retinopathy

NCT05344690

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2022-05-20

PhaseN/A

Study timeline

Study start (actual)2022-05-20Date precision: day

Registry last updated2024-02-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Retinopathyunresolved

Interventions

SLMAP and EPO genetic polymorphismGENETIC

Sponsors & collaborators

Ain Shams Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05344690 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.